Printer Friendly
The Free Library
19,595,263 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Anika Research changes corporate name to Anika Therapeutics.


WOBURN, Mass.--(BUSINESS WIRE)--Jan. 16, 1997--Anika Therapeutics Inc. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
 Small Cap: ANIK ANIK Canadian COMSAT ), formerly Anika Research Inc., today announced it has changed its corporate name to Anika Therapeutics Inc. to reflect its shift in emphasis from research and development to commercial sales.

The company's Nasdaq symbol will remain the same.

Anika is a leading developer and manufacturer of technologically advanced hyaluronic acid products for surgical and therapeutic medical applications. The company's commercial products include: ORTHOVISC for the treatment of osteoarthritis osteoarthritis
 or osteoarthrosis or degenerative joint disease

Most common joint disorder, afflicting over 80% of those who reach age 70. It does not involve excessive inflammation and may have no symptoms, especially at first.
; AMVISC to maintain eye shape and protect delicate tissues during ophthalmic surgery; and HYVISC for the treatment of equine osteoarthritis. Products under development include: INCERT for the prevention of surgical adhesions and HA oligosaccharides oligosaccharides (ol´igōsak´rīdz),
n.
 for the treatment of cancer.

CONTACT: Anika Therapeutics Inc.

Sean Moran, 617/932-6616

or

Pondel Parsons & Wilkinson

Susan Klein, 508/358-4315

Robert Whetstone whetstone, natural or manufactured stone used as an abrasive solid to sharpen tools. It is used dry, with water, or with oil. Such a stone of the finer grade used with oil is usually called an oilstone. , 310/207-9300
COPYRIGHT 1997 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1997, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jan 16, 1997
Words:139
Previous Article:CA-Paradigm Dramatically Improves Worker Productivity At Washington National Corp.
Next Article:RE: Maxwell Meighen and Associates - Performance of Canadian General Investments, Limited and Third Canadian General Investment Trust Limited.
Topics:



Related Articles
Anika Therapeutics Reports 1997 Year-End Results; Company Records First Year of Profitability.
ANIKA THERAPEUTICS Reports Second Quarter Results.
Anika Therapeutics Reports Hyaluronic Acid Enhanced Nerve Regeneration in Preclinical Study; Study Results Published in Journal of Microsurgery.
Anika Therapeutics Reports 1998 Fourth Quarter and Year-End Results; Records Second Consecutive Year of Profitability.
Anika Therapeutics Promotes Michael R. Slater To Vice President, Operations.
Anika Therapeutics Reports Second Quarter Results.
Anika Therapeutics Corrects and Replaces Previous Earnings Announcement, BW2993, MA-ANIKA.
Anika Therapeutics Completes Patient Enrollment in ORTHOVISC Phase III Clinical Study.
ANIKA INITIATES INCERT-S ANTI-ADHESION THERAPY CLINICAL TRIAL.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles